neutral amino acids การใช้

• Phenylalanine is a large, neutral amino acid ( LNAA ).
• Tentative evidence supports dietary supplementation with large neutral amino acids ( LNAAs ).
• Competition studies indicated that SnatA transports various L-type neutral amino acids.
• The protein phosphorylates several target proteins and has a role in neutral amino acid transport and activation of potassium and chloride channels.
• A gene encoding a small neutral amino acid transporter was cloned from the genome of the hyperthermophilic archaeon " Thermococcus " sp.
• AAAPs mediate cotransport of neutral amino acids with one proton, and uncharged forms of acidic and basic amino acids are cotransported with one proton.
• SLC6A19 is a system B ( 0 ) transporter that mediates epithelial resorption of neutral amino acids across the apical membrane in the kidney and intestine.
• Nicotinamide is necessary for neutral amino acid transporter production in the proximal renal tubules found in the kidney, and intestinal mucosal cells found in the small intestine.
• SLC3A2 comprises the heavy subunit of the "'large neutral amino acid transporter "'( "'LAT1 "') that is also known as CD98 ( cluster of differentiation 98 ).
• Eventually it was discovered that pregabalin is actively transported across the blood brain barrier by the system L neutral amino acid transporter protein, which usually functions to transport certain amino acids, including leucine, valine and isoleucine, into the brain.
• With urine chromatography, increased levels of neutral amino acids ( e . g ., glutamine, valine, phenylalanine, leucine, asparagine, citrulline, isoleucine, threonine, alanine, serine, histidine, tyrosine, tryptophan ) and indican are found in the urine.
• The neutral amino acid transporter " SLC6A19 " ( affecting glycine, proline, and other neutral amino acids like cysteine and tryptophan ), associated with Hartnup disease, plays a role in iminoglycinuria as a modifier to PAT2 mutations and is also directly affected by the actions of SIT1.
• The neutral amino acid transporter " SLC6A19 " ( affecting glycine, proline, and other neutral amino acids like cysteine and tryptophan ), associated with Hartnup disease, plays a role in iminoglycinuria as a modifier to PAT2 mutations and is also directly affected by the actions of SIT1.
• Tryptophan thus lowers in the brain as a result of the protein synthesis enhancement ( causing circulating tryptophan to lower more than other amino acids ), and perhaps also competition of large neutral amino acids for transport across the blood brain barrier through the large neutral amino acid transporter 1 ( LNAA1 ).
• Tryptophan thus lowers in the brain as a result of the protein synthesis enhancement ( causing circulating tryptophan to lower more than other amino acids ), and perhaps also competition of large neutral amino acids for transport across the blood brain barrier through the large neutral amino acid transporter 1 ( LNAA1 ).
• The oxytocin-like peptides, which differ in positions 4 and / or 8, include oxytocin ( Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with arginine-8 of AVT changed to leucine ), mesotocin ( arginine-8 changed to isoleucine ), and isotocin ( glutamine-4 changed to serine and arginine-8 changed to isoleucine ); they differ from the vasopressin-like peptides in having a neutral amino acid in place of a basic amino acid at position 8.